Original Article

Anti Leishmanial Effect of Plantago psyllium (Ovate) and White Vinegar on Leishmania major Lesion in BALB/c Mice


Background: Leishmania major is the etiologic agent of zoonotic cutaneous leishmaniasis in Iran, and glucantime in­jection is currently used for its treatment. This study aimed to evaluate the anti-leishmanial effect of topical Plantago psyllium and white vinegar in L. major infected BALB/c mice.

Methods: Thirty infected mice were divided into five groups as follows: Group‌ 1: treated with the combination of ovata powder and white vinegar, Group 2: treated with glucantime, Group 3: treated with white vinegar, Group 4: treated with the combination of ovata powder and water, and Group 5: without any treatment. All the groups were treated for 18 days. Lesion size was measured, and final smears were prepared for microscopic examination.

Results: The findings indicated that the difference in the mean areas of the ulcers in all the groups before and after treatment was not significant, except for the second (glucantime) and third (vinegar) groups. Also, the results showed that in the first, second, third, and fourth group, 6 (60%), 4 (80%), 3 (60%), and 2 (40%) mice were healed, respective­ly. However, ulcers remained in all the five mice of the control group.

Conclusion: The combination of ovata powder and white vinegar has been traditionally used to treat leishmanial lesions in Iran. It seems the most anti-leishmanial effect is related to vinegar and supported by Plantago. The route of treatment with this combination is very simple and painless in comparison with injection. Thus, further studies on this issue could help to design more effective and easy-to-use drugs.

1. Sarkari B, Ahmadpour NB, Moshfe A, Hajjaran H (2016) Molecular evaluation of a case of visceral leishmaniasis due to Leishmania tropica in southwestern Iran. Iran J Parasitol. 11(1): 126–130.
2. Bates PA (2007) Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies. Int J Parasitol. 37(10): 1097–1106.
3. Yazdanpanah MJ, Banihashemi M, Mohammadi SM, Hatami Z, Livani F, Esmaili H (2015) Clinical features of Old World cutaneous leishmaniasis in elderly patients. British J Dermatol. 172(2): 532–533.
4. Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R (2017) Leishmaniasis: a review. F1000Res. 6: 750.
5. Moein D, Masoud D, Saeed M, Abbas D (2018) Epidemiological Aspects of Cutaneous Leishmaniasis during 2009–2016 in Kashan City, Central Iran. Korean J Parasitol. 56(1): 21–24.
6. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J (2012) Leishmaniasis worldwide and global estimates of its incidence. PloS One. 7(5): e35671.
7. Salam N, Al-Shaqha WM, Azzi A (2014) Leishmaniasis in the Middle East: inci-dence and epidemiology. PLoS Negl Trop Dis. 8(10): e3208.
8. Norouzinezhad F, Ghaffari F, Norouzinejad A, Kaveh F, Gouya MM (2016) Cutaneous leishmaniasis in Iran: Results from an epidemiological study in urban and rural provinces. Asian Pac J Trop Biomed. 6(7): 614–619.
9. Sundar S, Chakravarty J (2015) An update on pharmacotherapy for leishmaniasis. Expert Opin Pharmacother. 16(2): 237–252.
10. Haldar AK, Sen P, Roy S (2011) Use of antimony in the treatment of leishmaniasis: current status and future directions. Mol Biol Int. 2011: 571242.
11. Zorbozan O, Harman M, Evren V, Erdoğan M, Kılavuz A, Tunalı V (2018) Infecting glial cells with antimony resistant Leishmania tropica: A new ex-vivo model. Mikrobiyol Bulteni. 52(1): 49–55.
12. Dujardin JC (2018) Epidemiology of leishmaniasis in the time of drug resistance (the miltefosine era). Drug Res Leishmania Parasites. 2018: 85–107.
13. Ponte-Sucre A, Gamarro F, Dujardin JC, Barrett MP, López-Vélez R, García-Her-nández R (2017) Drug resistance and treat¬ment failure in leishmaniasis: A 21st century challenge. PLoS Negl Trop Dis. 11(12): e0006052.
14. Moghaddas E, Khamesipour A, Mohebali M, Fata A (2017) Iranian native plants on treatment of cutaneous leishmaniosis: a narrative review. Iran J Parasitol. 12 (3): 312–322.
15. Oryan A (2015) Plant-derived compounds in treatment of leishmaniasis. Iran J Vet Res. 16(1): 1–19.
16. Soosaraei M, Fakhar M, Teshnizi SH, Hezarjaribi HZ, Banimostafavi ES (2017) Medicinal plants with promising antileishmanial activity in Iran: a systematic review and meta-analysis. Annals Med Surgery. 21: 63–80.
17. Izadi S, Mirhendi H, Jalalizand N, Khodadadi H, Mohebali M, Nekoeian S (2016) Molecular epidemiological survey of cutaneous leishmaniasis in two highly endemic metropolises of Iran, application of FTA cards for DNA extraction from Giemsa-stained slides. Jundishapur J Microbiol. 9(2): e32885.
18. Henry JC, Reedijk SH, Schallig HD (2015) Cutaneous leishmaniasis: recent developments in diagnosis and management. Am J Clin Dermatol. 16(2): 99–109.
19. Comini M, Flohé L, Jäger T, Oliver K (2013) Trypanosomatid Diseases: Molecular Routes to Drug Discovery. pp. 121–151.
20. Borazjani R, Aminnia S, Rastegarian M, Hosseini M, Ghanbarinasab Z, Ashkani-Esfahani S (2018) Effect of hydroalcoholic extract of Arnebia euchroma on the treatment of cutaneous leishmaniasis. J Clin Diagn Res. 12(8): 21–23.
21. Shirani-Bidabadi L, Mahmoudi M, Saberi S, Zolfaghari-Baghbaderani A, Nil-foroushzadeh MA, Abdoli H, Moatar F, Hejazi SH (2009) The effectiveness of mix extracts of thyme, yarrow and propolis on cutaneous leishmaniasis: a comparative study in animal model (BALB/c). Tehran Univ Med J. 66(11): 785–790.
22. Westerhof W, Das P, Middelkoop E, Verschoor J, Storey L, Regnier C (2001) Mucopolysaccharides from psyllium involved in wound healing. Clin Res Drugs Exp. 27(5–6): 165–175.
23. Ahmadi-Renani K, Mahmoodzadeh A, Cheraghali A, Esfahani A (2015) Effect of garlic extract on cutaneous leishmaniasis and the role of nitric oxide. Iran J Med Sci. 27(3): 97–100.
24. Doroodgar A, Arbabi M, Razavi MR, Mohebali M, Sadr F, Tashakkor Z (2007) Effect of Artemisia sieberi extract on Leishmania major ulcers in BALB/c mice. FEYZ. 11(3): 52–56.
25. Rocha L, Almeida J, Macedo R, Barbosa-Filho J (2005) A review of natural products with antileishmanial activity. Phytomedicine. 12(6–7): 514–535.
26. Chan-Bacab MJ, Peña-Rodríguez LM (2001) Plant natural products with leishmanicidal activity. Nat Prod Rep. 18(6): 674–688.
27. Da Silva BJM, Hage AAP, Silva EO, Rodrigues APD (2018) Medicinal plants from the Brazilian Amazonian region and their antileishmanial activity: a review. J Integr Med. 16(4): 211–222.
28. Nilforoushzadeh MA, Shirani-Bidabadi L, Zolfaghari-Baghbaderani A, Saberi S, Siadat AH, Mahmoudi M (2008) Comparison of Thymus vulgaris (thyme), Achillea millefolium (yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in BALB/c mice. J Vector Borne Dis. 45(4): 301–306.
29. Taran M, Mohebali M, Esmaeli J (2010) In vivo efficacy of gum obtained Pistacia atlantica in experimental treatment of cutaneous leishmaniasis. Iran J Public Health. 39(1): 36–41.
IssueVol 16 No 1 (2022) QRcode
SectionOriginal Article
DOI https://doi.org/10.18502/jad.v16i1.11191
Leishmaniasis Plantago psyllium Ulcer Mice

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Moshfe A, Karami K, Bahmani M, Naghmachi M, Askarian S, Rezaei A, Zare R, Jamshidi A. Anti Leishmanial Effect of Plantago psyllium (Ovate) and White Vinegar on Leishmania major Lesion in BALB/c Mice. J Arthropod Borne Dis. 2022;16(1):45–50.